pembrolizumab

Videos

Neoadjuvant Immune Checkpoint Inhibitors Unlikely Cost-Effective for Muscle-Invasive Bladder Cancer

02/25/2021

Journal of Clinical Pathways

Videos

Pembrolizumab Unlikely Cost-Effective for BCG-Unresponsive Bladder Cancer in US

02/17/2021

Journal of Clinical Pathways

Research in Review

First-Line Pembrolizumab for NSCLC Improves HRQoL Versus Chemotherapy

12/08/2016

JCP Editors

Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing...

...

12/08/2016

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

See Full Calendar

pembrolizumab

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products